Free Trial

Greenbrook TMS (GBNHF) Competitors

$0.02 0.00 (0.00%)
(As of 12:04 PM ET)

GBNHF vs. NIVF, ACON, BACK, UPHL, AVHIW, AVHIU, ACONW, AONC, BTTX, and DHACW

Should you be buying Greenbrook TMS stock or one of its competitors? The main competitors of Greenbrook TMS include NewGenIvf Group (NIVF), Aclarion (ACON), IMAC (BACK), UpHealth (UPHL), Achari Ventures Holdings Corp. I (AVHIW), Achari Ventures Holdings Corp. I (AVHIU), Aclarion (ACONW), American Oncology Network (AONC), Better Therapeutics (BTTX), and Digital Health Acquisition (DHACW). These companies are all part of the "healthcare" industry.

Greenbrook TMS vs.

Greenbrook TMS (NASDAQ:GBNHF) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking.

In the previous week, NewGenIvf Group had 4 more articles in the media than Greenbrook TMS. MarketBeat recorded 5 mentions for NewGenIvf Group and 1 mentions for Greenbrook TMS. NewGenIvf Group's average media sentiment score of 0.15 beat Greenbrook TMS's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Greenbrook TMS
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NewGenIvf Group
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NewGenIvf Group has a net margin of 0.00% compared to Greenbrook TMS's net margin of -73.08%.

Company Net Margins Return on Equity Return on Assets
Greenbrook TMS-73.08% N/A -84.92%
NewGenIvf Group N/A N/A N/A

NewGenIvf Group has lower revenue, but higher earnings than Greenbrook TMS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenbrook TMS$73.79M0.01-$48.91M-$1.24-0.01
NewGenIvf Group$5.14M0.40$130KN/AN/A

Greenbrook TMS has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500.

66.2% of NewGenIvf Group shares are held by institutional investors. 21.7% of Greenbrook TMS shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Greenbrook TMS and NewGenIvf Group both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Greenbrook TMSN/AN/A
NewGenIvf GroupN/AN/A

Summary

NewGenIvf Group beats Greenbrook TMS on 8 of the 10 factors compared between the two stocks.

Get Greenbrook TMS News Delivered to You Automatically

Sign up to receive the latest news and ratings for GBNHF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GBNHF vs. The Competition

MetricGreenbrook TMShealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$636,000.00$2.16B$5.09B$8.79B
Dividend YieldN/A7.23%5.04%4.07%
P/E Ratio-0.0111.4193.0914.02
Price / Sales0.016.101,220.6787.41
Price / CashN/A10.1339.4936.27
Price / Book-0.013.856.936.33
Net Income-$48.91M$69.56M$118.83M$225.71M
7 Day PerformanceN/A-2.24%-1.74%-0.58%
1 Month PerformanceN/A0.67%-3.60%1.49%
1 Year PerformanceN/A-19.41%31.91%27.23%

Greenbrook TMS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GBNHF
Greenbrook TMS
N/A$0.02
flat
N/AN/A$636,000.00$73.79M-0.01430Gap Down
NIVF
NewGenIvf Group
1.6259 of 5 stars
$0.55
-7.6%
N/AN/A$2.05M$5.14M0.00N/AGap Down
ACON
Aclarion
2.6062 of 5 stars
$0.18
-0.2%
$1.50
+752.3%
-95.9%$1.84M$80,000.000.007News Coverage
Positive News
BACK
IMAC
N/A$1.02
-1.0%
N/A-29.9%$1.17M$16.19M0.00180
UPHL
UpHealth
N/A$0.00
-50.0%
N/AN/A$19,000.00$130M0.001,750
AVHIW
Achari Ventures Holdings Corp. I
N/A$0.01
flat
N/AN/A$0.00N/A0.003
AVHIU
Achari Ventures Holdings Corp. I
N/A$10.00
flat
N/AN/A$0.00N/A0.003
ACONW
Aclarion
N/A$0.04
+43.9%
N/AN/A$0.00$49,289.000.007Gap Up
AONC
American Oncology Network
N/A$3.99
-7.0%
N/A-33.8%$0.00$1.34B0.001,520
BTTX
Better Therapeutics
N/AN/AN/AN/A$0.00N/A0.0040Gap Down
DHACW
Digital Health Acquisition
N/A$0.03
flat
N/A+77.3%$0.00N/A0.00N/A

Related Companies and Tools


This page (NASDAQ:GBNHF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners